InThePress

October 12, 2020

Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis

Read the article on our ERC grant “Clostridium-based Immunotherapy” which has been published on the CORDIS website in six languages at: https://lnkd.in/g5AQSvR
October 5, 2020

Bijna twee miljoen euro voor kankeronderzoek in het Maastricht UMC+

Is schildklierkanker te ruiken in uitademingslucht? Zijn bacteriën naar tumoren te sturen om daar medicijnen te produceren? KWF Kankerbestrijding investeert 1,8 miljoen euro in 3 onderzoeken […]
October 5, 2020

Obtaining research grants in times of corona

https://www.maastrichtuniversity.nl/news/obtaining-research-grants-times-corona
BUY NOW